Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (3 ops.)
Latest filing published 09 Nov 2015 for Valeant Pharmaceuticals International, Inc., €10.1M.
Insider track record
Disclosed buys
9
Disclosed sells
3
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
J. Michael Pearson: trading record in brief
J. Michael Pearson is a declared insider at 2 companies; the most frequent names are Valeant Pharmaceuticals International and Valeant Pharmaceuticals International, Inc. We count 39 filings; the first trade dates from 1 February 2008 and the latest from 5 November 2015.
Both buying and selling appear: 9 purchases worth €18.4M, against 3 sales worth €93.7M. Taken together, the sales exceed the purchases by €75.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 22 share grants and 1 option exercise. Since January 2015: no purchases and 3 sales on the market.
In size, the median ticket on the buying side is €533k.
On 9 November 2015 came the latest disclosure, an open-market sale for €10.1M in Valeant Pharmaceuticals International, Inc. The last purchase on record was published on 17 December 2013, which is 4,693 days ago. Typically, a trade is published a median of 4 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to J. Michael Pearson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
147,054 shares@ US$74.67Common Stock, no par valueSEC:0000885590-15-000078:0
800,345 shares@ US$76.66Common Stock, no par valueSEC:0000885590-15-000078:1
350,000 shares@ US$84.26Common Stock, no par valueSEC:0000885590-15-000078:2
86,641 shares0Common Stock, no par valueSEC:0000885590-15-000017:0
184,247 shares@ US$81.41Common Stock, no par valueSEC:0000885590-13-000101:0
Canonical exit: 14 Mar 2014 (T+90)
175,000 shares0Common Stock, no par valuesSEC:0000885590-12-000081:0
25,787 shares0Common Stock, no par valueSEC:0000885590-12-000066:0
101,877 shares0Common Stock, no par valuesSEC:0000885590-12-000026:0
502,998 shares0Common Stock, no par valuesSEC:0000885590-12-000025:0
7,294 shares0Common Stock, no par valuesSEC:0000885590-12-000025:1
49,539 shares0Common Shares, no par valueSEC:0001209191-12-007394:0
50,997 shares0Common Shares, no par valueSEC:0000885590-11-000086:0
155,642 shares0Common Shares, no par valueSEC:0000885590-11-000075:0
155,642 shares@ US$38.62Common Shares, no par valueSEC:0000885590-11-000057:0
Canonical exit: 9 Nov 2011 (T+90)
235,793 shares@ US$54.05Common Shares, no par valueSEC:0000885590-11-000023:0
929,364 shares@ US$39.50Common Shares, no par valueSEC:0000885590-11-000001:0
1,931,505 sharesCommon StockSEC:0001209191-10-051212:0
2,909,776 shares0Common Stock, no par valueSEC:0000885590-10-000048:0
1,665,410 shares0CommonSEC:0000885590-10-000048:1
5,961 shares@ US$33.72Common StockSEC:0001209499-10-000024:0
4,627 shares@ US$33.72Common StockSEC:0001209499-10-000024:1
21,252 shares@ US$33.72Common StockSEC:0001209499-10-000024:2
188,875 shares@ US$31.93Common StockSEC:0001209499-09-000109:0
5,898 shares@ US$24.73Common StockSEC:0001209499-09-000064:0
22,945 shares@ US$24.73Common StockSEC:0001209499-09-000064:1
25 of 39 declarations
